Melanoma epidemiology in Spain;Epidemiología del melanoma en España

Actas Dermo-Sifiliograficas

Volumn 96, Issue 7, 2005, Pages 411-418

  Sãenz, Soledad ^a,b   Conejo Mir, Julián ^a   Cayuela, Aurelio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b NONE   (Spain)

Author keywords

Cutaneous melanoma; Epidemiology; Spain

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; GENDER; HUMAN; MELANOMA; REVIEW; SPAIN; SURVIVAL RATE;

EID: 27244431580     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(05)73105-7     Document Type: Review

References (41)

1. Buendía A, Martínez C. Registres de cancer y cancer de piel. Piel. 1996;11:507-10.
2. Marks R. Epidemiology of melanoma. Clin Exp Dermatol. 2000;25:459-63.
3. Hall HI, Millar DR, Rogers JD. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol. 1999;40:35-42.
4. Garbe C, MacLeod GRC, Buether PG. Time trend of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer. 2000;89:1269-378.
5. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146 Suppl 61:1-6.
6. Ródenas JM, Delgado M, Herranz MT. Sun exposure, pigmentary traits and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control. 1996;7:275-83.
7. Parkin DW, Whelan SL, Ferlay J. Cancer Incidence in Five Continents, Volume VII. IARC Scientific Publications No. 143. Lyon: IARC, 1997.
8. McLennan R, Green AC, McLeod GR, Martin NG. Increasing incidente of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst. 1992;84:1427-32.
9. Burton RC. Malignan melanoma in the year 2000. CA Cancer J Clin. 2000;50:209-13.
10. Czarnecki D, Meehan CJ. Is the incidence of malignant melanoma decreasing in young Australians? J Am Acad Dermatol. 2000;42:672-4.
11. Ferlay J, Bray F, Pisani P, Parkin DM. Cancer incidence, mortality and prevalence worldwide, version 1.0. Lyon: IARC Press, 2001.
12. Boyle P, Smans M. Cancer mortality atlas of European Union, 1993-1997. Oxford: Oxford University Press, 2003.
13. Garbe C, Blue A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol. 2001;14:280-90.
14. Center for epidemiology, The Swedish Cancer Registry. Cancer Indidence in Sweden 2000. Stockholm: The Nacional Board of Health and Welfare, 2000.
15. Quinn M, Babb P, Brock A. Cancer trends in England and Wales 1950-1999. Office for Nacional Statistics: 2001; Studies on medical and populations subjectas, No. 66.
16. Mackie RM, Bray CA, Hole DJ, et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet. 2000;360:587-91.
17. Holme SA, Malinovsky K, Roberts DL. Malignant melanoma in South Wales: changing trends in presentation (1986-1998). Clin Exp Dermatol. 2001;26:484-9.
18. Vinceti M, Bergomi M, Borciani NM, et al. Rising melanoma incidente in an Italian community from 1986-1997. Melanoma Res. 1999;9:97-103.
19. De Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe, 1953-1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer. 2003;107:119-26.
20. Ardanaz IE, Moreno C, Pérez de Rada ME. Incidencia y mortalidad por cancer en Navarra, 1993-1997. Tendencia en los últimos 25 anos. Registro de Cáncer de Navarra. Sección de Enfermedades no Transmisibles y estadisticas vitales. An Sist Sanit Navar. 2001;24:339-62.
21. Moreno V, González JR, Soler M, Bosch FX, Kogevinas M, Borràs JM. Estimación de la incidencia de cancer en España: periodo 1993-1996. Gac Sanit. 2001;15:380-8.
22. Pollán M, López-Abente G. Mortality trends in cutaneous malignant melanoma in Spain, 1967-1986. Cancer Epidemiol Biomarkers Prev. 1993:2;545-50.
23. Oarkin DM, Whelan SL, Ferlay J. Cancer in Five Continents, vol. VIII. Lyon: IARC Scientific Publication; 1997. No. 143.
24. Ferlay J, Black RJ, Whelan SL. Electronic database of cancer incidente in five continents. Vol. VII. Lyon: IARC-WHO; 1997.
25. Parkin DM, Muir CS, Whelan SL. Cancer Incidence in Five Continents. Vol. VI. Lyon: IARC; 1992.
26. Buendia A, Ortega RM, Serrano S., ¿Han cambiado nuestros melanomas? Actas Dermosifiliogr. 1997;88:13-7.
27. Boring CC, Squires TS, Tong T. Cances statistiscs 1992; CA 1992;42:19-38.
28. Mackie RM, Aichinson T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br J Cancer. 1982;46:955-60.
29. Green A, McLennan R, Youll P. Site distribution of cutaneous melanoma in Queensland. Int J Cancer. 1993;53:232-6.
30. Ocana-Riola R, Martinez-Garcia C, Serrano S. Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985-1992. Eur J Epidemiol. 2001; 17:169-74.
31. Burton RC, Armstrong BK. Recent incidence trends imply a non-metastasising form of invasive melanoma. Melanoma Res. 1994;4:107-13.
32. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res. 2004; 14:301-9.
33. La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer. 1999;81:62-6.
34. Severi G, Giles GG, Robertson C. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer. 2000;82:1887-91.
35. López-Abente G, Pollán M, Aragonés N. Tendencia de la mortalidad en España 1952-1996. Efecto de la edad, de la cohorte de nacimiento y del periodo de muerte. Centro Nacional de Epidemiología. Instituto Carlos III. Madrid: Ministerio de Sanidad y Consume, 2002.
36. Nieto A, Ruiz-Ramos M, Andel-Kader L, Conde M, Camacho F. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98. Br J Dermatol. 2003;148:110-6.
37. Berrino F, Capocaccia R, Esteve J. Survival of cancer patients in Europe: the EUROCARE-2 Study. Lyon: IARC, 1999.
38. Smith JA, Whatley PM, Redburn JC. Improving survival of melanoma patients in Europe since 1978. Eur J Cancer. 1998;34:2197-203.
39. Mckie R, Hole D. Audi, of public education campaign to encourage earlier detection of malignant melanoma. BMJ. 2003;304:1012-5.
40. Coleman MP, Gata, G, Verdecchia A. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003;14 Suppl 5:128-49.
41. Sant M, Aareleid T, Berrino F, and the EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94. Results and commentary. Ann Oncol. 2003;14 Suppl 5:61-118.